{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:59:49Z","timestamp":1777377589810,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.autrev.2020.102616","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:20:04Z","timestamp":1594959604000},"page":"102616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pathogenesis of immune thrombocytopenia in common variable immunodeficiency"],"prefix":"10.1016","volume":"19","author":[{"given":"Elisa","family":"Tinazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Osti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruggero","family":"Beri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Argentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"Veneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Dima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Bason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnaneshwer","family":"Jadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Dolcino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102616_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.lpm.2014.01.010","article-title":"Pathogenesis of immune thrombocytopenia","volume":"43","author":"Cines","year":"2014","journal-title":"Presse Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102616_bb0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.21616","article-title":"Critical review the incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports","volume":"85","author":"Terrell","year":"2010","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102616_bb0015","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group standardization of terminology, definitions and outcome criteria in immune thrombocyt","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2020.102616_bb0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.autrev.2020.102616_bb0025","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102616_bb0030","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.12659\/MSM.895390","article-title":"CD16 and CD32 gene polymorphisms may contribute to risk of idiopathic thrombocytopenic purpura","volume":"22","author":"Xu","year":"2016","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.autrev.2020.102616_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MBC.0b013e32834ddf2f","article-title":"Fc\u03b3RIIa and Fc\u03b3RIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenicpurpura in Egypt","volume":"23","author":"Eyada","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.autrev.2020.102616_bb0040","first-page":"1):1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.autrev.2020.102616_bb0045","series-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","first-page":"3829","volume":"3(23)","author":"Neunert","year":"2019"},{"key":"10.1016\/j.autrev.2020.102616_bb0050","article-title":"CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2020.102616_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-017-0476-1","article-title":"Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open- label, multicenter, randomized controlled trial","volume":"10","author":"Li","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102616_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm.3770","article-title":"The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling","volume":"21","author":"Grozovsky","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2020.102616_bb0065","first-page":"773","article-title":"Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2020.102616_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-017-0413-3","article-title":"Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia","volume":"10","author":"Tao","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.autrev.2020.102616_bb0075","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2019.236117","article-title":"Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet life span","author":"Marini","year":"2019","journal-title":"Haematologica."},{"key":"10.1016\/j.autrev.2020.102616_bb0080","first-page":"6","article-title":"Ni H is platelet desialylation a novel biomarker and therapeutic target in immune thrombocytopenia?","volume":"2","author":"Li","year":"2020","journal-title":"J Cell Immunol"},{"key":"10.1016\/j.autrev.2020.102616_bb0085","first-page":"1","article-title":"Evaluating the effects of oseltamivir phosphate on platelet counts: a retrospective review","author":"Shaim","year":"2020","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.autrev.2020.102616_bb0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.autrev.2005.10.002","article-title":"Inflammatory and autoimmune clomplications of common variable immunodeficiency","volume":"5","author":"Knight","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102616_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2011.06377.x","article-title":"Common variable immunodeficiency (CVID): exploring the multiple dimensions of a heterogeneous disease","volume":"1250","author":"Salzer","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.autrev.2020.102616_bb0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ACI.0b013e32835914b9","article-title":"The many faces of the clinical picture of common variable immune deficiency","volume":"12","author":"Resnick","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102616_bb0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.18176\/jiaci.0069","article-title":"T-cell abnormalities in common variable immunodeficiency","volume":"26","author":"Azizi","year":"2016","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102616_bb0110","first-page":"1","article-title":"Immunophenotypic analysis of B lymphocytes in patients with common variable immunodeficiency: identification of CD23 as a useful marker in the definition of the disease","volume":"22","author":"Patuzzo","year":"2013","journal-title":"ISNR Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102616_bb0115","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1182\/blood-2004-04-1325","article-title":"Brief report common variable immunodeficiency is associated with defective functions of dendritic cells","volume":"104","author":"Bayry","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.autrev.2020.102616_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012652","article-title":"Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID)","volume":"5","author":"Carvalho","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.autrev.2020.102616_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2249.2012.04620.x","article-title":"Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels","volume":"169","author":"Barbosa","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102616_bb0130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.autrev.2016.07.011","article-title":"Autoimmunity and infection in common variable immunodeficiency (CVID)","volume":"15","author":"Patuzzo","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2020.102616_bb0135","first-page":"189","article-title":"Autoimmune cytopenias in common variable immunodeficiency","volume":"24","author":"Podjasek","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102616_bb0140","series-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","first-page":"77","volume":"111(1)","author":"Wehr","year":"2013"},{"issue":"24","key":"10.1016\/j.autrev.2020.102616_bb0145","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21 - human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102616_bb0150","first-page":"2","article-title":"Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency","volume":"9(3)","author":"Yazdani","year":"2014","journal-title":"Adv Biomed Res"},{"issue":"2","key":"10.1016\/j.autrev.2020.102616_bb0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","article-title":"T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections","volume":"170","author":"Bateman","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102616_bb0160","first-page":"397","article-title":"Common variable immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia","volume":"5","author":"Jan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102616_bb0165","series-title":"T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency","first-page":"309","volume":"118(2)","author":"Ochtrop","year":"2011"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722030183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722030183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:19:56Z","timestamp":1761599996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722030183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S156899722030183X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102616","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of immune thrombocytopenia in common variable immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102616"}}